These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 17364475)

  • 81. Pegylation, a Successful Strategy to Address the Storage and Instability Problems of Blood Products: Review 2011-2021.
    Mehrizi TZ; Mirzaei M; Ardestani MS
    Curr Pharm Biotechnol; 2024; 25(3):247-267. PubMed ID: 37218184
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Hexa-thiocarbamoyl phenyl PEG5K Hb: vasoactivity and structure: influence of rigidity of the conjugation linkage on the PEGylation induced plasma expander-like solution properties of PEG-Hb adducts.
    Meng F; Manjula BN; Tsai AG; Cabrales P; Intaglietta M; Smith PK; Prabhakaran M; Acharya SA
    Protein J; 2009 Jun; 28(5):199-212. PubMed ID: 19653083
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Determination of potassium in red blood cells using unmeasured volumes of whole blood and combined sodium/potassium-selective membrane electrode measurements.
    Pietrzak M; Meyerhoff ME
    Anal Chem; 2009 Jul; 81(14):5961-5. PubMed ID: 19601656
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Site-specific modification and PEGylation of pharmaceutical proteins mediated by transglutaminase.
    Fontana A; Spolaore B; Mero A; Veronese FM
    Adv Drug Deliv Rev; 2008 Jan; 60(1):13-28. PubMed ID: 17916398
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Synthesis of degradable functional poly(ethylene glycol) analogs as versatile drug delivery carriers.
    Wang N; Dong A; Tang H; Van Kirk EA; Johnson PA; Murdoch WJ; Radosz M; Shen Y
    Macromol Biosci; 2007 Nov; 7(11):1187-98. PubMed ID: 17665412
    [TBL] [Abstract][Full Text] [Related]  

  • 86. In vitro quality of red blood cells (RBCs) collected by multicomponent apheresis compared to manually collected RBCs during 49 days of storage.
    Picker SM; Radojska SM; Gathof BS
    Transfusion; 2007 Apr; 47(4):687-96. PubMed ID: 17381628
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Camouflaged blood cells: low-technology bioengineering for transfusion medicine?
    Scott MD; Bradley AJ; Murad KL
    Transfus Med Rev; 2000 Jan; 14(1):53-63. PubMed ID: 10669940
    [TBL] [Abstract][Full Text] [Related]  

  • 88. An autoanti-Kp b immunoglobulin M that simulates antigen suppression.
    Bosco A; Xenocostas A; Kinney J; Cadwell CM; Zimring JC
    Transfusion; 2009 Apr; 49(4):750-6. PubMed ID: 19170996
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Bioreversibly crosslinked polyplexes of PEI and high molecular weight PEG show extended circulation times in vivo.
    Neu M; Germershaus O; Behe M; Kissel T
    J Control Release; 2007 Dec; 124(1-2):69-80. PubMed ID: 17897749
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Dynamic and structural aspects of PEGylated liposomes monitored by NMR.
    Leal C; Rögnvaldsson S; Fossheim S; Nilssen EA; Topgaard D
    J Colloid Interface Sci; 2008 Sep; 325(2):485-93. PubMed ID: 18589432
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Modification of antimicrobial peptide with low molar mass poly(ethylene glycol).
    Zhang G; Han B; Lin X; Wu X; Yan H
    J Biochem; 2008 Dec; 144(6):781-8. PubMed ID: 18845567
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Determinant factors for an apparent increase in oxygen affinity of senescent human erythrocytes.
    Romero PJ; Romero EA
    Acta Cient Venez; 2004; 55(1):83-5. PubMed ID: 15916168
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Peptide and protein PEGylation: a review of problems and solutions.
    Veronese FM
    Biomaterials; 2001 Mar; 22(5):405-17. PubMed ID: 11214751
    [TBL] [Abstract][Full Text] [Related]  

  • 94. A new approach for PEGylation of dendrimers.
    Khambete H; Gautam SP; Karthikeyan C; Ramteke S; Hari Narayana Moorthy NS; Trivedi P
    Bioorg Med Chem Lett; 2010 Jul; 20(14):4279-81. PubMed ID: 20558063
    [TBL] [Abstract][Full Text] [Related]  

  • 95. PEGylation--a well-proven strategy for the improvement of recombinant drugs.
    Zündorf I; Dingermann T
    Pharmazie; 2014 May; 69(5):323-6. PubMed ID: 24855821
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Blood Group Antigen Shielding Facilitated by Selective Cell Surface Engineering.
    Jiang L; Liu H; Huang C; Shen X
    ACS Appl Mater Interfaces; 2020 May; 12(20):22426-22432. PubMed ID: 32347090
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Quest for universal red cell units.
    Mohanty D
    Indian J Med Res; 2007 Sep; 126(3):174-5. PubMed ID: 18037708
    [No Abstract]   [Full Text] [Related]  

  • 98. Decreased agglutinability of human erythrocytes by attachment of methoxy polyethylene glycol and the effect on erythrocyte oxygen-carrying ability.
    Ong K; Dimacali K; Quintos R
    Clin Hemorheol Microcirc; 2003; 29(3-4):401-7. PubMed ID: 14724367
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Will stealth RBCs replace blood donors of rare types?
    Garratty G
    Vox Sang; 2002 Aug; 83 Suppl 1():101-4. PubMed ID: 12617114
    [No Abstract]   [Full Text] [Related]  

  • 100. Tunable thioesters as "reduction" responsive functionality for traceless reversible protein PEGylation.
    Chen J; Zhao M; Feng F; Sizovs A; Wang J
    J Am Chem Soc; 2013 Jul; 135(30):10938-41. PubMed ID: 23848502
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.